Abstract
In a retrospective study 133 patients (64 men, 69 women) with myelodysplastic syndromes (MDS) were analyzed. The patients were middle-aged to elderly (median 70 years; range 38–88 years), and according to the French-American-British Group (FAB) criteria they were diagnosed as having: refractory anemia (RA), 36; refractory sideroblastic anemia (RAS), 16; RA with excess of blasts (RAEB), 23; chronic myelomonocytic leukemia (CMML), 46; and RAEB in transformation (RAEBT), 12.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Krieger, O., Lutz, D. (1993). Prognosis of Myelodysplastic Syndromes. In: Fleischer, J. (eds) Leukemias. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77083-8_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-77083-8_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77085-2
Online ISBN: 978-3-642-77083-8
eBook Packages: Springer Book Archive